Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TAKARA BIO INC Amends Consolidated Mid-year Forecast for FY 2014


Thursday, 24 Oct 2013 02:00am EDT 

TAKARA BIO INC announced that it has lowered the consolidated mid-year forecast for revenue from JPY 10,300 million to JPY 10,277 million but raised the forecast for operating profit from JPY 300 million to JPY 454 million, ordinary profit from JPY 310 million to JPY 493 million, net profit from JPY 130 million to JPY 227 million and earning per share from JPY 1.14 to JPY 1.98 for the fiscal year ending March 31, 2014. The Company amended the consolidated mid-year outlook due to decreased sales and decreased cost. 

Company Quote

1602.0
4.0 +0.25%
16 Sep 2014